免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ART-Plan+ (v3.1.0)

K 號:K253091 · 2025-12-23

決定日期2025-12-23
產品代碼MUJ
諮詢委員會RA
決定相當於

器材摘要

ART-Plan+ (v3.1.0) is the device name listed in this FDA 510(k) record. The listed applicant is Therapanacea Sas. It received FDA 510(k) clearance on 2025-12-23 under 510(k) number K253091. The device is classified under product code MUJ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ART-Plan+ (v3.1.0)?

ART-Plan+ (v3.1.0) is a medical device that received FDA 510(k) clearance on 2025-12-23. The listed applicant is Therapanacea Sas. The 510(k) number is K253091.

When did ART-Plan+ (v3.1.0) receive FDA 510(k) clearance?

ART-Plan+ (v3.1.0) received FDA 510(k) clearance on 2025-12-23, under 510(k) number K253091.

Who is the listed applicant for ART-Plan+ (v3.1.0)?

The FDA 510(k) record lists Therapanacea Sas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ART-Plan+ (v3.1.0)?

The FDA product code for ART-Plan+ (v3.1.0) is MUJ.

其他以 Therapanacea Sas 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:MUJ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑